Sana Biotechnology, Inc.

NASDAQ:SANA

Biotechnology

Healthcare
$1.74 +1.23%

+$0.04 today

Market cap
$521.36M
Beta
2.16
P/E (TTM)
-3.5
EPS (TTM)
-$0.87
52W Low $2.58High $6.55

Volume 4.00M

Average 3.76M

Returns on capital

Sana Biotechnology, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-151.8%

avg -25.0%

ROIC

-54.1%

avg -40.3%

ROA

-58.6%

avg -41.9%

Analysis

ROIC is currently the strongest return metric at -54.1% versus its period average of -40.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Steven D. Harr

President, Chief Executive Officer & DirectorUSD 1.15M56——

Brian D. Piper

Executive Vice President & Chief Financial OfficerUSD 653.04K54——

Dhavalkumar D. Patel

Executive Vice President & Chief Scientific Officer—65——

Gary Meininger

Executive VP & Chief Medical Officer————

Yuko Soneoka

SVP & Head of Intellectual Property————

Aaron Grossman

Executive VP, Chief Legal Officer & Corporate Secretary—54——

John Gerecitano

Senior Vice President, Clinical Lead, Hematology & Oncology Development————

Snehal Patel

Executive VP & Chief Technical Officer————

Debra Wisdom

VP & Head of People————

Susan Wyrick

Treasurer, Principal Accounting Officer and Senior VP of Finance & Accounting—53——

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A2 analysts
RevenueN/AN/AN/A
N/A2 analysts
Net IncomeN/AN/AN/A
N/A2 analysts
EBITN/AN/AN/A
N/A2 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Sana Biotechnology, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about SANA's management, answered from reported figures.

Who manages SANA?

Sana Biotechnology, Inc. (SANA) lists 10 active executives. The top listed executive is Dhavalkumar D. Patel, Executive Vice President & Chief Scientific Officer.

Are SANA insiders buying or selling?

Recent insider activity shows net buying of $66.08M.